BioWorld

June 30, 2003

View Archived Issues

GSK Spin-Off Affymax Generates $20M In Private Financing Round

Affymax Inc. closed a $20 million private round of financing that coincided with the drug discovery and development firm's appointment of a new chief executive. (BioWorld Today) Read More

CBER, CDER Consolidation Plan Goes Into Effect Today

Read More

To Detect Infectious Pathogens In Body, Pasteur Scientists Unravel Adaptive Immunity From Innate

Read More

Inex 'Bought-Deal' Agreement To Raise $18.6M For Pipeline

Read More

Labopharm Raising C$22M As It Nears Tramadol Application

Read More

Other News To Note

Read More

Appointments And Advancements

Read More